IOmega-6 yeFatty Acids

Umxholo

• Kusenokwenzeka ukuba ayisebenzi ...
• Akukho bungqina baneleyo bokulinganisa ukusebenza ...
• Amanyathelo okhuseleko kunye nezilumkiso:

I-Omega-6 fatty acids ziintlobo zamafutha. Ezinye iintlobo zifumaneka kwioyile yemifuno, kubandakanya umbona, imbewu yeprimrose yangokuhlwa, isaflower kunye neoyile yeembotyi zesoya. Ezinye iintlobo ze-omega-6 fatty acids zifumaneka kwimbewu ye-currant emnyama, imbewu ye-borage, kunye neoyile ye-primrose yangokuhlwa.

I-Omega-6 fatty acids isetyenziselwa iimeko ezininzi, kodwa ukuza kuthi ga ngoku, olona lwazi lubalulekileyo lunokunikwa sisayensi kukuba ukubeka i-arachidonic acid, i-omega-6 ye-acid enamafutha, kwifomula yeentsana ayikuphuculi ukukhula kosana. Akukho phando lwaneleyo lwenziweyo kwi-omega-6 fatty acids ukugweba ukuba ziyasebenza kusini na kolunye usetyenziso.

Uninzi lolwazi esinalo kwi-omega-6 fatty acid supplements ivela ekufundeni i-omega-6 fatty acids okanye iioyile zezityalo eziqukethe i-omega-6 fatty acids. Jonga uluhlu olwahlukileyo lwe-gamma linolenic acid, kunye ne-primrose yangokuhlwa, i-borage, kunye ne-currant emnyama.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe I-OMEGA-6 FATTY ACIDS zezi zilandelayo:

Kusenokwenzeka ukuba ayisebenzi ...

• Isifo sentliziyo. Uninzi lophando lubonisa ukuba ukutya okuphezulu kwe-omega-6 fatty acids akuwunciphisi umngcipheko wesifo sentliziyo okanye iziganeko ezinxulumene nentliziyo. Kukho ubungqina bokuba iintlobo ezahlukeneyo ze-omega-6 fatty acids zinokuchaphazela intliziyo kunye nemithambo yegazi ngokwahlukileyo. Kodwa oku kusafuna ukuqinisekiswa.
• Ukukhula komntwana. Ukongeza i-omega-6 fatty acid arachidonic acid kunye ne-omega-3 fatty acid ebizwa ngokuba yi-docosahexaenoic acid (DHA) kwifomula yeentsana akubonakali kuphucula ukukhula kwengqondo, umbono, okanye ukukhula kweentsana.
• Multiple sclerosis (MS). Ukuthatha i-omega-6 fatty acids akubonakali ngathi kuthintela ukuqhubela phambili kwe-MS.

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

• Yehla kwimemori nakwizakhono zokucinga ezenzeka ngesiqhelo ngobudala. Uphando lwakwangoko lubonisa ukuba abantu abane-omega-6 ene-acid eninzi emzimbeni wabo okanye abatya ngaphezulu omega-6 okunamafutha acid ekutyeni kunokuba kuncinci ukuba kunciphe kwimemori nakwizakhono zokucinga kunye nobudala.
• Ukuqwalaselwa kwentsilelo-yokuchaphazeleka kwengqondo (ADHD). Uphando lwakwangoko lubonisa ukuba ukuthatha indibaniselwano ye-omega-3 kunye ne-omega-6 fatty acids kabini ngemini kangangeenyanga ezi-3-6 ayiziphuculi iimpawu ze-ADHD.
• Ukudumba kwamehlo (i-blepharitis). Abantu abatya isixa esilinganiselweyo se-omega-6 fatty acids babonakala benomngcipheko ophantsi wokuphuhlisa uhlobo oluthile lokudumba kwejwabu leso. Kodwa ukutya elona xabiso liphezulu akubonakali kunceda. Ukuthatha i-omega-6 ye-acid ene-asidi yokuncedisa kunokunceda ukuphucula iimpawu ezinjenge-cloudness kubantu abane-eyelid edema. Kodwa uphando olukumgangatho ophezulu luyafuneka ukuqinisekisa.
• Ukuphazamiseka kwezakhono zemoto okuphawulwe kukungazinzi (ukukhula kokulungelelanisa ukuphazamiseka okanye iDCD). Uphando lwakwangoko lubonisa ukuba ukuthatha indibaniselwano ye-omega-6 kunye ne-omega-3 fatty acids kwiinyanga ezi-3 kunokuphucula ukufunda, upelo, kunye nokuziphatha, kodwa hayi ukulungelelanisa okanye intshukumo kubantwana abaneDCD.
• Seswekile. Abantu abanexabiso eliphezulu le-omega-6 ye-acid enqatyisiweyo emzimbeni wabo akunakufane kwenzeke ukuba babe neswekile kunabantu abanexabiso eliphantsi. Kodwa ukufumana okuninzi i-omega-6 fatty acids kwizongezo okanye ukutya akubonakali kunciphisa umngcipheko wesifo seswekile.
• Urhudo. Uphando lwakwangoko lubonisa ukuba iintsana zondla ifomula zongezwa nge-omega-6 fatty acid ebizwa ngokuba yi-arachidonic acid kunye ne-omega-3 fatty acid ebizwa ngokuba yi-docosahexaenoic acid (DHA) kunyaka wokuqala wobomi inomngcipheko ophantsi wokurhuda.
• Iliso elomileyo. Ukutya okuphezulu kwe-omega-6 fatty acids ayinxulunyaniswa nomngcipheko omncinci wamehlo owomileyo.
• Igazi elonyukayo. Abantu abasempilweni abatya ngaphezulu omega-6 okunamafutha acid banokuba nomngcipheko ophantsi wokukhula koxinzelelo lwegazi. Kodwa ukutya ukutya okuphezulu kwe-omega-6 fatty acids kunxulunyaniswe nomngcipheko okonyukayo woxinzelelo lwegazi kubantu abanesifo seswekile.
• Ukubuyiselwa kwimeko yoqhaqho lweliso le-laser (i-keratectomy esebenzayo). Uphando lwakwangoko lubonisa ukuba ukuthatha i-omega-6 fatty acids kunye ne-beta-carotene kunye neevithamini ze-B kunokunceda ekuvuseleleni kuqhaqho lwamehlo lwe-laser.
• Usulelo lweendlela zomoya. Uphando lwakwangoko lubonisa ukuba iintsana zondla ifomula zongezwa nge-omega-6 fatty acid ebizwa ngokuba yi-arachidonic acid kunye ne-omega-3 fatty acid ebizwa ngokuba yi-docosahexaenoic acid (DHA) kunyaka wokuqala wobomi inomngcipheko ophantsi wosulelo lomoya.
• Ukunciphisa amanqanaba amabi e-cholesterol (LDL).
• Ukwandisa amanqanaba e-cholesterol (HDL).
• Ukunciphisa umngcipheko womhlaza.
• Ezinye iimeko.

Ubungqina obungakumbi buyafuneka ukukala ukusebenza kwe-omega-6 fatty acids kwezi zinto zisetyenziswayo.

I-Omega-6 fatty acids ifumaneka kuyo yonke indawo emzimbeni. Banceda ngokusebenza kwazo zonke iiseli. Ukuba abantu abatyi ngokwaneleyo i-omega-6 fatty acids, iiseli azizukusebenza ngokufanelekileyo. Uninzi lwe-omega-6 fatty acids inokutshintsha indlela iiseli ezisabela ngayo kwaye zibe neziphumo ezinobungozi kwiiseli ezisentliziyweni nakwimithambo yegazi.

Xa kuthathwa ngomlomo: I-Omega-6 fatty acids yile NGOKUKHUSELEKILEYO xa kutyiwa ngabantu abadala kunye nabantwana abangaphezulu kweminyaka yeenyanga ezili-12 njengenxalenye yokutya kubungakanani obuphakathi kwe-5% kunye ne-10% yeekhalori zemihla ngemihla. Nangona kunjalo, akukho lwazi lwaneleyo lunokufumaneka ukuze wazi ukuba i-omega-6 fatty acids zikhuselekile ukuba zingasetyenziswa njengeyeza.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa kunye nokuncancisa: I-Omega-6 fatty acids yile NGOKUKHUSELEKILEYO xa isetyenziswa njengenxalenye yokutya kwixabiso eliphakathi kwe-5% kunye ne-10% yeekhalori zemihla ngemihla. Ukungena okuphezulu OKUNGENZEKA UKHUSELEKILE njengoko banokwandisa umngcipheko wokuba nosana oluncinci okanye ukuba nomntwana onokhwekhwe. Akukho lwazi lwaneleyo lwanokuthenjwa lokwazi ukuba ngaba i-omega-6 fatty acid supplements zikhuselekile ukuba zingasetyenziswa xa ukhulelwe okanye uncancisa. Hlala kwicala elikhuselekileyo kwaye uphephe ukusetyenziswa.

Isifo semiphunga esenza ukuba kube nzima ukuphefumla (isifo esinganyangekiyo semiphunga okanye isifo seCOPD): I-Omega-6 fatty acids ingenza ukuphefumla kube nzima ngakumbi kubantu abaneCOPD. Sukusebenzisa i-omega-6 fatty acids ukuba uneCOPD.

SeswekileUkutya okuphezulu kwe-omega-6 fatty acids kukutya kunokunyusa umngcipheko wokuba noxinzelelo lwegazi kubantu abanesifo seswekile. Kude kube kwaziwa ngakumbi, ungasebenzisi i-omega-6 fatty acid supplements ukuba unesifo seswekile.

I-triglycerides ephezulu (uhlobo lwamafutha): I-Omega-6 fatty acids inokuphakamisa amanqanaba e-triglyceride. Sukusebenzisa i-omega-6 fatty acids ukuba ii-triglycerides zakho ziphezulu kakhulu.

Ayaziwa ukuba le mveliso iyasebenzisana nawaphi na amayeza.

Ngaphambi kokuba uthathe le mveliso, thetha nengcali yezempilo ukuba ngaba uthatha nawaphi na amayeza.

Akukho kunxibelelana kwaziwayo kunye namayeza kunye nezongezo.

Akukho kunxibelelana kwaziwayo nokutya.

Idosi efanelekileyo ye-omega-6 fatty acids ixhomekeke kwizinto ezininzi ezinje ngeminyaka yomsebenzisi, impilo, kunye nezinye iimeko. Ngeli xesha akukho lwazi lwaneleyo lwesayensi ukumisela uluhlu olufanelekileyo lweedosi ze-omega-6 fatty acids. Gcina ukhumbula ukuba iimveliso zendalo azisoloko zikhuselekile kwaye iidosi zibalulekile. Qiniseka ukuba ulandela umkhombandlela ofanelekileyo kwiilebheli zemveliso kwaye uqhagamshelane nosokhemesti okanye ugqirha okanye olunye uqeqesho kwezempilo ngaphambi kokusebenzisa.

I-Acides Gras Essentiels N-6, Acides Gras Oméga-6, Acides Gras Omégas 6, Acides Gras Polyinsaturés, Acidos Grasos Omega 6, AGE, AGPI, Huiles d'Oméga 6, N-6, N-6 EFAs, N-6 Kubalulekile I-Fatty Acids, i-Omega 6, i-Omega-6 Polyunsaturated Fatty Acids, i-Omega 6 Oils, iiPolyunsaturated Fatty Acids, ii-PUFA.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.

1. UGardner KG, uGebretsadik T, uHartman TJ, et al. I-omega-3 yangaphambi kokubeleka kunye ne-omega-6 ye-polyunsaturated fatty acids kunye ne-atopic dermatitis yobuntwana. J Ikliniki ye-Allergy Pract Immun. Ngo-2020; 8: 937-944. Jonga i-abstract.
2. UDong X, Li S, Chen J, Li Y, Wu Y, Zhang D. Umbutho wokutya ω-3 kunye no-ω-6 okunamafutha e-acid edla ngokusebenza kwengqondo kubantu abadala: Uphando lweSizwe lwezeMpilo kunye noVavanyo lweSondlo (NHANES) 2011-2014 . Isondlo J. 2020; 19:25. Jonga i-abstract.
3. UBrown TJ, uBrainard J, Ingoma F, et al. I-Omega-3, i-omega-6, kunye nokutya okupheleleyo kwe-polyunsaturated fat yokuthintela kunye nokunyanga uhlobo lwe-2 yeswekile: ukuphononongwa ngokuchanekileyo kunye nohlalutyo lweemeta zezilingo ezilawulwa ngokungahleliwe. BMJ. Ngo-2019; 366: l4697. Jonga i-abstract.
4. Henderson G, Crofts C, Schofield G.Linoleic acid kunye nokuthintela isifo seswekile. ILancet yeswekile i-Endocrinol. NgoJanuwari 2018; 6: 12-13. Jonga i-abstract.
5. I-Assmann KE, Adjibade M, Hercberg S, Galan P, Kesse-Guyot E.I-acid engafakwanga i-acid ethathwa ngexesha lokuphila phakathi kobomi inxulunyaniswa ngokuqinisekileyo nomsebenzi wokuqonda kamva kubantu abadala abaneziphumo zokuguqula ukongezwa kwe-antioxidant. J Isondlo. 2018; 148: 1938-1945. Jonga i-abstract.
6. UZiemanski JF, uWolters LR, uJones-Jordan L, uNichols JJ, uNichols KK. Ubudlelwane phakathi kokutya okune-fatty acid yokutya kunye nesifo esomileyo samehlo kunye nokungasebenzi kakuhle kwamadlala kwi-postmenopausal. NdinguJ Ophthalmol. Ngo-2018; 189: 29-40. Jonga i-abstract.
7. Ukurutha uS, uPapanicolaou M, Xenaki D, et al. Ukutya? -6 polyunsaturated fatty acid arachidonic acid yonyusa ukudumba, kodwa inqanda ukubonakaliswa kweprotein ye-ECM kwi-COPD. Ukuphefumla Res. Ngo-2018; 19: 211. Jonga i-abstract.
8. UNakamura H, Hara A, Tsujiguchi H, et al. Ubudlelwane phakathi kokutya oku-n-6 okunamafutha acid ukutya kunye noxinzelelo lwegazi: Iziphumo zamanqanaba e-hemoglobin eglycated. Izondlo. 2018; 10. IPH: E1825. Jonga i-abstract.
9. IHarris WS, iTintle NL, iRamachandran VS. I-Erythrocyte n-6 fatty acids kunye nomngcipheko weziphumo zentliziyo kunye nokufa okupheleleyo kwisifundo sentliziyo seFramingham. Izondlo. 2018; 10. pii: E2012. Jonga i-abstract.
10. UHooper L, uAl-Khudairy L, u-Abdelhamid AS, et al. Amafutha e-Omega-6 kuthintelo lokuqala kunye nolwesibini lwesifo sentliziyo. Isiseko sedatha yeCochrane Isityhi. 2018; 11: CD011094. Jonga i-abstract.
11. UJasani B, uSimmer K, uPatole SK, uRao SC. Ikhonkco elide le-polyunsaturated fatty acid supplementation kwiintsana ezizalwe ngexesha. Isiseko sedatha yeCochrane Syst Rev 2017; 3: CD000376. Jonga i-abstract.
12. Inyanga K, Rao SC, Schulzke SM, Patole SK, Simmer K. Longchain polyunsaturated fatty acid supplementation kwiintsana zaphambi kwexesha. Isiseko sedatha yeCochrane Syst Rev 2016; 12: CD000375. Jonga i-abstract.
13. UDelgado GE, März W, uLorkowski S, von Schacky C, uKleber ME. I-Omega-6 fatty acids: imibutho echaseneyo nomngcipheko-Umngcipheko weLudwigshafen kunye nesifundo seMpilo yeNtliziyo. J Ikliniki ye-Lipidol 2017; 11: 1082-90.e14. Jonga i-abstract.
14. Lemoine Soto CM, Woo H, Romero K, et al. Umbutho we-omega-3 kunye ne-omega-6 fatty acid intake kunye nokudumba kunye neziphumo zokuphefumla kwi-COPD. NdinguJ J woKhathalelo ngeMeko yoKhathalelo. 2018; 197: A3139.
15. I-Pawelczyk T, Trafalska E, Pawelczyk A, Kotlicka-Antczak M. Umahluko kwi-omega-3 kunye ne-omega-6 polyunsaturated fatty acid usetyenziso lwabantu abasemngciphekweni ophezulu wengqondo yengqondo, isiqendu sokuqala schizophrenia, kunye nolawulo olusempilweni. Ukuqala kwengqondo kwi-Psychiatry 2017; 11: 498-508. Jonga i-abstract.
16. UWu JHY, uMarklund M, u-Imamura F, uCohorts woPhando lweNtliziyo kunye nokuGuga kwi-Genomic Epidemiology (CHARGE) Fatty Acids kunye neZiphumo zoPhando lwe-Consortium (FORCE). I-Omega-6 fatty acid biomarkers kunye nohlobo lwesigulo sesi-2 seswekile: Uhlalutyo oluhlanganisiweyo lwedatha yenqanaba lomntu ngamnye kuma-39? Abantu abadala abangama-740 abavela kwizifundo ezingama-20 ezinokubakho. ILancet yeswekile i-Endocrinol 2017; 5: 965-74. Jonga i-abstract.
17. U-Lee E, uKim H, uKim H, uHa EH, u-Chang N. Umbutho we-omega-6 ye-fatty acid yokutya kunye neziphumo zokuzalwa kosana: Oomama baseKorea kunye neMpilo yezeNdalo yaBantwana (MOCEH). Isondlo J 2018; 17: 47. Jonga i-abstract.
18. Lapillonne A, Pastor N, Zhuang W, Scalabrin DMF. Iintsana zondla ifomula ngokudityaniswa kwamafutha e-polyunsaturated fatty ziye zanciphisa imeko yezifo zokuphefumla kunye norhudo kunyaka wokuqala wobomi. BMC Pediatr. Ngo-2014; 14: 168. Jonga i-abstract.
19. Socha, P., Koletzko, B., Swiatkowska, E., Pawlowska, J., Stolarczyk, A., kunye no-Socha, J. Essential fatty acid metabolism kwiintsana ezine cholestasis. Acta Paediatr. Ngo-1998; 87: 278-283. Jonga i-abstract.
20. U-Godley, P.A., Campbell, M.K, Gallagher, P., Martinson, F. E., Mohler, J. L., kunye no-Sandler, R. S. Biomarkers zokusetyenziswa okunamafutha acid kunye nomngcipheko we-prostatic carcinoma. Umhlaza we-Epidemiol. Ngo-1996; 5: 889-895. Jonga i-abstract.
21. I-Peck, MD, iMantero-Atienza, E., Miguez-Burbano, MJ, Lu, Y., Fletcher, MA, Shor-Posner, G., kunye neBaum, MK Iprofayili ye-asidi yeplastikhi eqinisekisiweyo iyatshintshwa kwi-HIV-1 yokuqala. usulelo. IiLipids 1993; 28: 593-597. Jonga i-abstract.
22. UGibson, R. A., Teubner, J. K., Haines, K., Cooper, D. M., noDavidson, G. P. Ubudlelwane phakathi kokusebenza kwepulmonary kunye namanqanaba e-asidi enamafutha e-plasma kwizigulana ze-cystic fibrosis. J Isidlangalala seGastroenterol Nutriti 1986; 5: 408-415. Jonga i-abstract.
23. I-Tso, P. kunye ne-Hayashi, H. I-physiology kunye nommiselo wokufakwa kwamathumbu emathunjini kunye nokuhanjiswa kwe-omega-3 kunye ne-omega-6 fatty acids. U-Adv Prostaglandin Thromboxane Leukot. 1989; 19: 623-626. Jonga i-abstract.
24. URaz, R. kunye noGabis, L.Amanqatha abalulekileyo e-acid kunye ne-deficit-hyperactivity disorder: uphononongo olucwangcisiweyo. Umntwana ophakathi kwi-Neurol. Ngo-2009; 51: 580-592. Jonga i-abstract.
25. Harris, WS, Mozaffarian, D., Rimm, E., Kris-Etherton, P., Rudel, LL, Appel, LJ, Engler, MM, Engler, MB, kunye neeNgxowa, F. Omega-6 fatty acids kunye nomngcipheko isifo sentliziyo: ingcebiso ngezesayensi evela kwiKomitana ye-American Heart Association Nutrition yeBhunga kwiZondlo, Umsebenzi woMzimba, kunye neMetabolism; IBhunga kwi-Nursing Cardiovascular; kunye neBhunga kwi-Epidemiology kunye noThintelo. Ukujikeleza kwe2-17-2009; 119: 902-907. Jonga i-abstract.
26. Querques, G., Russo, V., Barone, A., Iaculli, C., noDelle, Noci N. [Ukusebenza kwe-omega-6 kunyango lwe-asidi enamafutha ngaphambi nasemva kwe-keratectomy ye-photorefractive]. J Fr Ophtalmol. Ngo-2008; 31: 282-286. Jonga i-abstract.
27. Simopoulos, A. P. I-omega-6 / omega-3 fatty ratio, ukwahluka kwemfuza, kunye nesifo sentliziyo. I-Asia Pac. J yeKlinikhi yeNutrr 2008; 17 Suppl 1: 131-134. Jonga i-abstract.
28. I-Laidler, P., Dulinska, J., kunye neMrozicki, S. Ngaba ukuthintela intetho ye-c-myc kulamla umsebenzi wokuchasana nethumba ye-ligand ye-PPAR kwimigca yeseli yomhlaza webele? IArch. Ibhayoloji. 6-1-2007; 462: 1-12. Jonga i-abstract.
29. Nielsen, AA, Nielsen, JN, Gronbaek, H., Eivindson, M., Vind, I., Munkholm, P., Brandslund, I., kunye noHey, H. Impembelelo yezongezelelo zokungenisa ezityetyiswe nge-omega-3 fatty acids kunye / okanye i-omega-6 fatty acids, arginine kunye neeribonucleic acid iikhompawundi kumanqanaba e-leptin kunye nenqanaba lesondlo kwisifo sikaCrohn esisebenzayo siphathwe nge-prednisolone. Ukugaya ukutya ngo-2007; 75: 10-16. Jonga i-abstract.
30. I-Pinna, A., i-Piccinini, i-P, kunye ne-Carta, F. Iziphumo ze-linoleic yomlomo kunye ne-gamma-linolenic acid kwi-meibomian gland dysfunction. ICornea 2007; 26: 260-264. Jonga i-abstract.
31. Sonestedt, E., Gullberg, B., kunye noWirfalt, E. Zombini utshintsho kumkhwa wokutya kwixa elidlulileyo kunye nenqanaba lokutyeba kakhulu kunokuba nefuthe kumanyano phakathi kokutya kunye nomhlaza wamabele we-postmenopausal. IzeMpilo yoLuntu 2007; 10: 769-779. Jonga i-abstract.
32. UMartinez-Ramirez, M. J., Palma, S., Martinez-Gonzalez, M. A., Delgado-Martinez, A. D., de la Fuente, C., kunye noDelgado-Rodriguez, M. Ukutya amanqatha okutya kunye nomngcipheko wokuqhekeka kwe-osteoporotic kubantu abadala. I-Eur. J yeKlinikhi yeNutriti 2007; 61: 1114-1120. Jonga i-abstract.
33. UFarinotti, M., Simi, S., Di, Pietrantonj C., McDowell, N., Brait, L., Lupo, D., kunye noPhilippini, G. Ungenelelo lokutya kwi-multiple sclerosis. Cochrane.Database.Syst.Rev 2007; CD004192. Jonga i-abstract.
34. Okuyama, H., Ichikawa, Y., Ilanga, Y., Hamazaki, T., kunye neMihlaba, thina somhlaza esiqhelekileyo e-USA sikhuthazwa yi-omega 6 fatty acids kunye nesixa esikhulu samafutha ezilwanyana, kodwa sicinezelwe yi-omega 3 fatty acids kunye necholesterol. Ukutya kwiNdawo yeHlabathi yeZondlo. Ngo-2007; 96: 143-149. Jonga i-abstract.
35. UMamalakis, G., Kiriakakis, M., Tsibinos, G., Hatzis, C., Flouri, S., Mantzoros, C., noKafatos, A. Uxinzelelo kunye ne-serum adiponectin kunye ne-adipose omega-3 kunye ne-omega-6 fatty acids kulutsha. I-Pharmacol. I-Biochem. IBehav. Ngo-2006; 85: 474-479. Jonga i-abstract.
36. I-Hughes-Fulford, M., Tjandrawinata, R. R., Li, C. F., kunye no-Sayyah, S. Arachidonic acid, i-omega-6 fatty acid, induces cytoplasmic phospholipase A2 kwiiseli zeprotate carcinoma. ICarcinogenesis 2005; 26: 1520-1526. Jonga i-abstract.
37. IGrimble, R. F.Ukungabikho kokutya. I-Curr Opin. IGastroenterol 2005; 21: 216-222. Jonga i-abstract.
38. I-Chiplonkar, S. A., Agte, V. V., Tarwadi, K. V., Paknikar, K. M., kunye noDiwate, U. P. Iziphene zokunqongophala kwezinto ezinokubangela uxinzelelo lwegazi kubantu abadala baseIndiya. NdinguColl Nutr 2004; 23: 239-247. Jonga i-abstract.
39. I-Assies, J., Lok, A., Bockting, CL, Weverling, GJ, Lieverse, R., Visser, I., Abeling, NG, Duran, M., kunye ne-Schene, AH Fatty acids kunye namanqanaba e-homocysteine ​​kwizigulana eziphindaphindayo. Uxinzelelo: isifundo esilingwayo sokuhlola. IProstaglandins Leukot, i-Essent, iiFatty Acids, 2004; 70: 349-356. Jonga i-abstract.
40. IMelnik, B. kunye nePlewig, G. Ngaba ukuphazamiseka kwe-omega-6-fatty acid metabolism ibandakanyeka kwi-pathogenesis ye-atopic dermatitis? Umthetho we-Acta Derm.Venereol.Suppl (iStockh) 1992; 176: 77-85. Jonga i-abstract.
41. URichardson, A. J., uCyhlarova, uE, noRoss, M. A. Omega-3 kunye ne-omega-6 fatty concentrations kwiimbumba zegazi ezibomvu zihambelana neempawu ze-schizotypal kubantu abadala abasempilweni. Iprostaglandins Leukot. I-Acid ye-Fatty 2003; 69: 461-466. Jonga i-abstract.
42. ICunnane, S. C. Iingxaki ngamafutha abalulekileyo: lixesha leparadigm entsha? Inkqubo yePlip Res 2003; 42: 544-568. Jonga i-abstract.
43. UMunoz, S. E., Piegari, M., Guzman, C. A., kunye no-Eynard, A. R. Iziphumo ezahlukileyo zokutya kwe-Oenothera, i-Zizyphus mistol, kunye neoyile yombona, kunye nokusilela kwe-acid okunamafutha ekuqhubekeni kwesifo se-murine mammary gland adenocarcinoma. Isondlo 1999; 15: 208-212. Jonga i-abstract.
44. IHodge, L., Salome, CM, Hughes, JM, Liu-Brennan, D., Rimmer, J., Allman, M., Pang, D., Armor, C., kunye neWoolcock, AJ Iziphumo zokutya kwi-omega -3 kunye ne-omega-6 fatty acids ebukrakra be-asthma ebantwaneni. Ukuphefumla kwe-Eur. J 1998; 11: 361-365. Jonga i-abstract.
45. UVentura, H. O., Milani, R. V., uLavie, uC. J., Smart, F. W., uStapleton, D. D., amaToups, uT. S., kunye neXabiso, H.L.Cyclosporine-eyenze uxinzelelo lwegazi. Ukusebenza kwe-omega-3 fatty acids kwizigulana emva kokufakelwa kwentliziyo. Ukujikeleza kwe1993; 88 (5 Pt 2): II281-II285. Jonga i-abstract.
46. UMargolin, G., Huster, G., Glueck, CJ, Speirs, J., Vandegrift, J., Illig, E., Wu, J., Streicher, P., kunye noTracy, T. Uxinzelelo lwegazi lwehla kwizifundo zabantu abadala. : Isifundo esiphindwe kabini esingaboniyo se-omega-3 kunye ne-omega-6 fatty acids. NdinguJ J weeKlinikhi ngo-1991; 53: 562-572. Jonga i-abstract.
47. UJohnson, M., Ostlund, S., Fransson, G., Kadesjo, B., noGillberg, C. Omega-3 / omega-6 fatty acids for ingqalelo deficit hyperactivity disorder: ityala elilawulwa ngokungahleliwe kwi-placebo ebantwaneni nakwishumi elivisayo . J. Ingxaki. Ngo-2009; 12: 394-401. Jonga i-abstract.
48. Aupperle, R. L., Denney, D. R., Lynch, S. G., Carlson, S. E., kunye noSullivan, D. K. Omega-3 fatty acids kunye ne-multiple sclerosis: ubudlelwane noxinzelelo. J Behav Med 2008; 31: 127-135. Jonga i-abstract.
49. I-Conklin, S. M., Manuck, S. B., Yao, J. K., Flory, J. D., Hibbeln, J. R., kunye no-Muldoon, M. F. I-omega-6 ephezulu kunye ne-omega-3 fatty acids ezinxulumene neempawu zokudakumba kunye ne-neuroticism. Ingqondo. Ngo-2007; 69: 932-934. Jonga i-abstract.
50. Yamada, T., Strong, JP, Ishii, T., Ueno, T., Koyama, M., Wagayama, H., Shimizu, A., Sakai, T., Malcom, GT, kunye noGuzman, MA Atherosclerosis kunye ne-omega -3 fatty acids kubemi belali yokuloba kunye nelali yokulima eJapan. I-Atherosclerosis 2000; 153: 469-481. Jonga i-abstract.
51. IColter, A.L, Cutler, C., kunye neMeckling, K. A. Inqanaba le-asidi ye-asidi kunye neempawu zokuziphatha zentsilelo yokuphazamiseka kwengqondo kulutsha: isifundo solawulo lwamatyala. Isondlo J 2008; 7: 8. Jonga i-abstract.
52. Ukutya kunye neBhodi yeZondlo, iZiko lezeMpilo. Ukungeniswa kwereferensi yokutya kwi-eneji, i-Carbohydrate. Ifayibha, Amafutha, Amanqatha Acids, iCholesterol, iProteni, kunye neeAmino Acids. IWashington, DC: ICandelo leSizwe lezeMfundo, 2005. Iyafumaneka apha: http://www.nap.edu/books/0309069351/html/
53. URichardson AJ, uMontgomery P.Uphononongo lweOxford-Durham: ulingo olungenamkhethe, olulawulwayo lokongezwa kokutya kunye nee-acid ezinamafutha kubantwana abanengxaki yokulungelelanisa ukukhula. Iipedatifikethi 2005; 115: 1360-6. Jonga i-abstract.
54. Ukutya kunye neBhodi yeZondlo, iZiko lezeMpilo. Ukungeniswa kwereferensi yokutya kwi-eneji, i-Carbohydrate, iFibre, iFat, iiFatty Acids, iCholesterol, iProtein, kunye neeAmino Acids (Macronutrients). IWashington, DC: ICandelo lezeMfundo kuZwelonke, 2002. Iyafumaneka apha: http://www.nap.edu/books/0309085373/html/.
55. Umntu omtsha weLM, uKing IB, uWicklund KG, uStanford JL. Umanyano lweeasidi ezinamafutha kunye nomngcipheko womhlaza wedlala lesinyi IProstate 2001; 47: 262-8. Jonga i-abstract.
56. I-Leventhal LJ, iBoyce EG, iZurier RB. Unyango lwe-rheumatoid arthritis ene-gammalinolenic acid. UAnn Intern Med 1993; 119: 867-73. Jonga i-abstract.
57. UNoguchi M, uRose DP, u-Earashi M, uMiyazaki I. Indima ye-fatty acids kunye ne-eicosanoid synthesis inhibitors kwi-carcinoma yebele. Oncology 1995; 52: 265-71. Jonga i-abstract.
58. URose DP. Isizathu sobuchule bokuxhasa ukuthintelwa komhlaza ekudleni. Edlulileyo ngeMed 1996; 25: 34-7. Jonga i-abstract.
59. UMalloy MJ, uKane JP. Iiarhente ezisetyenziswa kwi-hyperlipidemia. Ku: B. Katzung, ed. Isiseko kunye neKlinikhi yeFarmacology. Ngomhla we-4. INorwald, CT: Appleton kunye neLange, 1989.
60. Godley PA. Ukusetyenziswa okunamafutha acid kunye nomngcipheko womhlaza webele. Unyango lomhlaza wamabele kunyango luka-1995; 35: 91-5. Jonga i-abstract.
61. IGibson RA. I-chain-polyunsaturated fatty acids kunye nophuhliso lweentsana (uhlelo). ILancet 1999; 354: 1919.
62. ULucas A, uStafford M, uMorley R, et al. Ukusebenza kunye nokukhuseleka kwexesha elide le-polyunsaturated fatty acid yokuxhasa ubisi olungumgubo lweentsana: ityala elingahleliwe. ILancet 1999; 354: 1948-54. Jonga i-abstract.

Ukuhlaziywa okokugqibela-11/19/2020